Compare Orchid Chemicals with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs STRIDES PHARMA SCIENCE - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

STRIDES PHARMA SCIENCE 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD STRIDES PHARMA SCIENCE ORCHID PHARMA LTD/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x -0.5 15.5 - View Chart
P/BV x 0.1 0.9 12.9% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ORCHID PHARMA LTD   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
STRIDES PHARMA SCIENCE
Mar-18
ORCHID PHARMA LTD/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs1941,147 16.9%   
Low Rs35642 5.5%   
Sales per share (Unadj.) Rs276.5317.2 87.1%  
Earnings per share (Unadj.) Rs-79.27.8 -1,009.7%  
Cash flow per share (Unadj.) Rs-43.525.1 -173.4%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs53.9274.3 19.7%  
Shares outstanding (eoy) m70.4589.50 78.7%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x0.42.8 14.7%   
Avg P/E ratio x-1.4114.0 -1.3%  
P/CF ratio (eoy) x-2.635.7 -7.4%  
Price / Book Value ratio x2.13.3 65.1%  
Dividend payout %025.5 0.0%   
Avg Mkt Cap Rs m8,06780,058 10.1%   
No. of employees `0002.82.5 111.7%   
Total wages/salary Rs m2,5274,341 58.2%   
Avg. sales/employee Rs Th6,956.111,325.8 61.4%   
Avg. wages/employee Rs Th902.51,731.4 52.1%   
Avg. net profit/employee Rs Th-1,993.0280.1 -711.6%   
INCOME DATA
Net Sales Rs m19,47728,394 68.6%  
Other income Rs m407941 43.3%   
Total revenues Rs m19,88429,334 67.8%   
Gross profit Rs m1,1033,965 27.8%  
Depreciation Rs m2,5191,540 163.5%   
Interest Rs m5,2271,962 266.3%   
Profit before tax Rs m-6,2361,403 -444.4%   
Minority Interest Rs m200-   
Prior Period Items Rs m0-168 0.0%   
Extraordinary Inc (Exp) Rs m511-436 -117.3%   
Tax Rs m-12597 -128.7%   
Profit after tax Rs m-5,580702 -794.8%  
Gross profit margin %5.714.0 40.5%  
Effective tax rate %2.06.9 29.0%   
Net profit margin %-28.72.5 -1,158.7%  
BALANCE SHEET DATA
Current assets Rs m11,01424,836 44.3%   
Current liabilities Rs m32,06018,993 168.8%   
Net working cap to sales %-108.120.6 -525.1%  
Current ratio x0.31.3 26.3%  
Inventory Days Days9571 133.7%  
Debtors Days Days34113 29.6%  
Net fixed assets Rs m29,44034,289 85.9%   
Share capital Rs m705895 78.7%   
"Free" reserves Rs m2,04323,651 8.6%   
Net worth Rs m3,80024,546 15.5%   
Long term debt Rs m9,01815,513 58.1%   
Total assets Rs m46,51065,437 71.1%  
Interest coverage x-0.21.7 -11.3%   
Debt to equity ratio x2.40.6 375.5%  
Sales to assets ratio x0.40.4 96.5%   
Return on assets %-0.84.1 -18.7%  
Return on equity %-146.92.9 -5,134.0%  
Return on capital %-3.76.9 -54.2%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Exports (fob) Rs m7,378NA-   
Imports (cif) Rs m4,406NA-   
Fx inflow Rs m7,51315,697 47.9%   
Fx outflow Rs m5,649735 768.1%   
Net fx Rs m1,86514,962 12.5%   
CASH FLOW
From Operations Rs m1,6821,871 89.9%  
From Investments Rs m-9,8605,826 -169.3%  
From Financial Activity Rs m6,644-10,157 -65.4%  
Net Cashflow Rs m-1,535-2,615 58.7%  

Share Holding

Indian Promoters % 32.3 27.7 116.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 37.8 12.2%  
FIIs % 3.3 8.6 38.4%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 25.9 213.5%  
Shareholders   84,811 56,241 150.8%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  FULFORD INDIA  PROCTER & GAMBLE HEALTH  

Compare ORCHID PHARMA LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Over 100 Points Down; Banking and IT Stocks Under Pressure(09:30 am)

Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.9% while the Hang Seng is also down 0.9%.

Related Views on News

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 432 m (up 1048.1% YoY). Sales on the other hand came in at Rs 7 bn (up 3.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, STRIDES PHARMA SCIENCE has posted a net profit of Rs 316 m (down 27.5% YoY). Sales on the other hand came in at Rs 8 bn (up 6.1% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - SANOFI INDIA COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS